is associated with a central fat distribution and risk of developing type 2 diabetes in adults when exposed to a sedentary Western lifestyle. Increased lipolysis is an early defect of metabolism in IUGR subjects, but the sites and molecular mechanisms involved are unknown. Twenty IUGR and 20 control (CON) subjects, aged 20 -30 years, were studied before and after 10 days of bed rest using the glucose clamp technique combined with measurements of in vivo metabolism by microdialysis technique and blood flow by 133 Xe washout technique in subcutaneous abdominal (SCAAT) and femoral (SCFAT) adipose tissue. Additionally, mRNA expression of lipases was evaluated in biopsies from SCAAT. Lipolysis in SCAAT was substantially higher in IUGR than in CON subjects despite markedly lower mRNA expression of lipases. Blood flow was higher in IUGR compared with CON in both SCAAT and SCFAT. Whole body insulin sensitivity did not differ between groups and decreased after bed rest. After bed rest, SCAAT lipolysis remained higher in IUGR compared with CON, and SCFAT lipolysis decreased in CON but not in IUGR. Prior to the development of whole body insulin resistance, young men with IUGR are characterized by increased in vivo adipose tissue lipolysis and blood flow with a paradoxically decreased expression of lipases compared with CON, and 10 days of physical inactivity underlined the baseline findings. Subjects with IUGR exhibit primary defects in adipose tissue metabolism.
LBW; IUGR; adipose tissue metabolism; insulin resistance A LARGE NUMBER OF STUDIES indicate that an adverse intrauterine environment resulting in intrauterine growth retardation (IUGR) is associated with an increased risk of developing type 2 diabetes later in life (13, 15, 22, 28, 33, 34, 37) , but the mechanisms underlying the risk remain unclear. Individuals born with IUGR may exhibit an abnormal development pattern of the adipose tissue during fetal and postnatal life, by displaying a reduced body fat mass at birth and catch up growth during infancy and childhood involving the adipose tissue (32, 36) . Indeed, adult subjects born with IUGR commonly exhibit high body fat mass with central fat distribution (25, 38, 49) . Adipose tissue is supposed to play a key role in the development of insulin resistance (23, 39) , and the abnormal growth and composition of adipose tissue in individuals with IUGR might contribute to a later development of whole body (5) as well as adipose tissue insulin resistance (27) . The contribution of the adipose tissue in the pathophysiology of insulin resistance is partly based on its lipolytic activity, resulting in mobilization of free fatty acids, which, when increased, are deleterious for glucose utilization and insulin action. Jaquet et al. (19) previously found that in individuals born with IUGR a decreased peripheral glucose uptake during a hyperinsulinemic, euglycemic clamp was associated with a dampened antilipolytic action of insulin as reflected by reduced suppression of plasma free fatty acids. Patel and Kalhan (35) showed an early defect in whole body lipolysis as rate of appearance of glycerol was higher in 48-h-old infants with IUGR compared with infants born appropriate for gestational age. Later studies revealed an increased rate of lipolysis in isolated adipocytes from IUGR subjects (47) and, by use of the microdialysis technique, an increased rate of adipose tissue lipolysis in response to catecholamine infusions has been shown in IUGR subjects (5) . Using stable glycerol isotopes, we recently found an increased rate of whole body lipolysis in young and healthy IUGR subjects prior to the development of whole body insulin resistance (1). The adipose tissue regional sites responsible for the increased lipolysis in subjects with IUGR and the molecular mechanisms involved are still to be identified.
Scientific studies present clear evidence of a causal association between aerobic fitness and health (14, 24, 48, 51) . Relative to the large amount of data describing the acute and chronic effects of exercise, relatively little is known about the biological mechanisms and physiological responses caused by sedentary behaviors. Data are necessary to describe how alterations in the time engaged in sedentary behaviors impact the metabolic processes involved in the etiology of type 2 diabetes. Insulin sensitivity is directly related to the level of physical activity (41) , and intervention studies have shown that physical inactivity elevates the risk of type 2 diabetes even in normal weight individuals (17, 24) . As such, physical inactivity is an independent risk factor for insulin resistance and type 2 diabetes. Sedentariness could be the environmental trigger that unmasks increased disease susceptibility in healthy subjects predisposed to develop insulin resistance making it possible to observe potential pathophysiological defects in adipose tissue metabolism.
The aim of this study was thus 1) to compare basal health outcomes related to subcutaneous adipose tissue metabolism in healthy but sedentary type 2 diabetes predisposed individuals and appropriate control (CON) subjects and 2) to study potential effects of a 10-day bed rest intervention on these health outcomes.
MATERIALS AND METHODS
The data presented in this article are part of a larger study on the influence of physical inactivity in healthy and prediabetic subjects as initiated and funded within the framework program of the European Union's EXGENESIS Consortium. Other findings in the same cohort of subjects have been published previously (1-4, 16, 42-44) .
Subjects. Forty young healthy men, 20 IUGR and 20 CON, participated in the study and were allocated via the Danish National Birth Registry. IUGR had birth weight Ͻ10 percentile and CON between the 50 and 75 percentile (IUGR: 2,548 Ϯ 53 g; CON: 3,827 Ϯ 49 g; P Ͻ 0.001). All subjects were from singleton pregnancies born at term (IUGR: 40 Ϯ 0.2 wk; CON: 40 Ϯ 0.1 wk; P Ͼ 0.05). During inclusion, groups were matched according to age, body mass index (BMI), and physical fitness. Only subjects with normal fasting glucose (Ͻ5.6 mmol/l) who did not use any medication or had first degree relatives with type 2 diabetes were selected. Additional inclusion criteria were male, Caucasian, age 20 -30 years, maximal oxygen uptake (V O2max) 35 Pre-and posttesting. Fasting plasma glucose was determined in arterial blood using an ABL 625 (Radiometer, Copenhagen, DK). Body composition was determined by dual-energy X-ray absorptiometry (DEXA) full body scanning (DPX-IQ, software version 4.7e, Lunar Radiation, Madison, WI). V O2max was measured using a bicycle ergometer exercise protocol by means of an Oxycon Pro System (Jaeger, Höchberg, Germany).
Study design. All subjects participated in one experimental day ϳ3 wk before 10 days of strict bed rest. On the 10th day of the bed rest period, subjects participated in the second and identical experimental day. Four days before the first experimental day subjects were provided a standardized isocaloric diet (55 E% of carbohydrates, 15 E% of protein, and 30 E% of fat). Caloric fluids, including alcohol, were prohibited. During these 4 days as well as during the bed rest period a combined accelerometer and heart rate sensor (Actiheart; Cambridge Neurotechnology, Cambridge, UK) registered movements and heart rate and the energy expenditure was calculated. The Actiheart device was placed on the subject's upper left chest clipped on two standard electrocardiogram electrodes. Subjects were instructed to continue their daily living activities including physical activity habits during the 4 days and in the 3 wk prior to the bed rest period and to refrain from vigorous physical activity 24 h prior to the first experimental day. In the bed rest period the subjects were in bed all day (a maximum of 60°upper body elevation was allowed) under surveillance. The standardized isocaloric diet was provided during bed rest with adjusted reduced amounts to ensure weight stability.
Experimental day protocol. The experimental day consisted of a 210-min baseline period followed by a 180-min hyperinsulinemic euglycemic clamp. Microdialysis catheters were inserted and dialysate was sampled during the last 60 min of baseline and the last 60 min of the clamp period. Subcutaneous adipose tissue blood flow was measured continuously alongside microdialysis sampling. An arterial catheter (Becton-Dickinson, Great Britain) was inserted in the brachial artery for blood sampling and a venous catheter (18G Venflon, Medex Medicine, Great Britain) was inserted in the medial antecubital vein for infusion of insulin and glucose.
Microdialysis. One microdialysis catheter (CMA60, CMA Microdialysis AB, Solna, Sweden) was inserted in SCAAT and another catheter was inserted in SCFAT as previously described (16) . The catheters were perfused with Ringer acetate containing 2 mM glucose (Skanderborg Apotek, Skanderborg, Denmark) at 1 l/min using a high precision syringe pump (CMA100, CMA Microdialysis AB). Microdialysate was collected and stored at Ϫ20°C. The relative recovery (RR) over the membrane was determined in all microdialysis catheters using internal reference calibration (29) as previously described (16) . The absolute rate of exchange of glucose, glycerol, and lactate was calculated using Fick's equation as described previously (45, 46 
Data are presented as means Ϯ SE. *P: significant difference between the groups before bed rest. †P: significant difference before vs. after bed rest within controls (CON). ‡P: significant difference before vs. after bed rest within subjects with intrauterine growth retardation (IUGR). ns, Nonsignificant; nm: not measured. Resting energy expenditure (REE), active energy expenditure (AEE), total energy expenditure (TEE), and physical activity level (PAL) are based on Actiheart recordings during 4 days of daily living 3 wk before bed rest and during bed rest.
Biochemical analysis.
Blood samples for analysis of glucose, glycerol, lactate, free fatty acids, and triglyceride were distributed in iced tubes containing 1.5 mg ethylene-diamine-tetraacetic acid per milliliter blood. For analysis of insulin the tubes contained 500 KIE Trasylol and 1.5 mg EDTA per milliliter blood. The tubes were centrifuged (Hettich Labinstrument ApS, Hvidovre, Denmark) and stored at Ϫ80°C. Plasma and microdialysate glucose, glycerol, and lactate were determined by a CMA600 Microdialysis Analyser (CMA Microdialysis AB). Plasma free fatty acids were determined using a nonesterified fatty acids (NEFA) C kit (Wako Chemicals, Neuss, Germany). Plasma insulin analysis was determined by ELISA technique (DAKO ELISA, UK) and plasma triglyceride with triglyceride GPO-PAP (Roche Diagnostic, Mannheim, Germany).
Adipose tissue blood flow. Subcutaneous adipose tissue blood flow was measured by the local 133 Xe washout technique (26) . Gaseous 133 Xe (0.5-1 MBq; Amersham Health, Amersham, UK) was injected into the subcutaneous abdominal (SCAAT) and femoral (SCFAT) adipose tissue contralateral to the regions in which microdialysis was performed. Washout of 133 Xe was registered by a Mediscint system (Oakfield Instruments, Oxford, UK), and adipose tissue blood flow was calculated as described previously by Bulow and Madsen (7) .
Whole body glucose uptake. Whole body glucose disposal was determined using the hyperinsulinemic (40 mU·min Ϫ1 ·m Ϫ2 , Actrapid, Novo Nordisk, Copenhagen, Denmark), euglycemic clamp technique as described previously (44) . Whole body insulin-mediated glucose uptake rates were averaged for 10-min periods and calculated as the mean of steady-state glucose infusion rates (M-value).
Adipose tissue biopsies. SCAAT biopsies were collected in the basal state and in the end of a 180-min hyperinsulinemic (80 mU·min Ϫ1 ·m Ϫ2 ), euglycemic clamp before bed rest and on the 9th day of the bed rest intervention using the Bergstrom biopsy needle technique. Biopsies were frozen in liquid nitrogen and stored at Ϫ80°C.
Determination of mRNA levels. Total RNA was isolated using Trizol reagent (Gibco BRL, Life Technologies, Roskilde, Denmark) and cDNA was made with random hexamer primers using the GeneAmp PCR kit (Applied Biosystems, CA). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was chosen as housekeeping gene for hormone-sensitive lipase (HSL), lipoprotein lipase (LPL), and adipose triglyceride lipase (ATGL) and ␤-actin as housekeeping gene for glucose transporter protein 4 (GLUT4). GAPDH and ␤-actin were chosen as reference genes since these genes displayed low intervention variability vs. other potential reference genes (S18 rRNA, ␤2-mikroglobulin, hypoxanthine phosphoribosyl-transferase, RNA polymerase 2 alpha subunit, ribosomal protein L4). Housekeeping genes were tested for stability during the intervention in random samples from the intervention groups. GAPDH and ␤-actin expressions were unchanged during the intervention (P ϭ 0.49 and P ϭ 0.40, respectively) and expression levels did not differ significantly between IUGR and CON subjects. Quantification was performed with a SYBR-Green real time PCR assay using an iCycler PCR machine (Bio-Rad Laboratories, Hercules, CA) as previously described (6) .
Statistical analysis. SAS for Windows version 9.1 (SAS Institute, Cary, NC) was used for statistical analysis. Data were analyzed using a linear mixed model with a random person effect where results are adjusted for variation within persons. The model estimates differences between mean values. The figures presented ( Fig. 1-3 ) are absolute means, while the differences and confidence intervals (CI) described in results, are from the linear mixed model. If data were not normally distributed or homogeneous as assessed by residual plots of each dependent variable, log transformation data were used and significant effects described as relative (%) differences. We evaluated the effect of groups (CON and IUGR), effect of bed rest (before vs. after) and time (baseline or insulin stimulated), and tested an eventual differential effect of bed rest between IUGR and CON by testing interaction between groups and bed rest, including the marginal effects in the model. Threshold for significance was P Յ 0.05. The Bonferroni corrected P value that is equivalent to an uncorrected P value of 0.05 in the present study is P ϭ 0.0028, although this is likely overly conservative. Data are presented as absolute means Ϯ SE (figures) or differences and CI.
RESULTS
Anthropometrics and physical activity. IUGR subjects were characterized by increased abdominal adiposity (trunk fat mass/total fat mass) compared with CON but similar body mass index and waist/hip ratio (Table 1) . In response to bed rest, no changes in anthropometrics were observed. Total, resting, and activity-related energy expenditure as well as the physical activity score (Actiheart recordings) did not differ between groups during daily living but decreased in both groups during bed rest with no difference between groups ( Table 1 ). The V O 2max per kilogram body weight did not differ between groups (Table 1) .
Whole body insulin sensitivity. Before bed rest, whole body insulin sensitivity (M-value) did not differ between IUGR and CON (IUGR: 6.2 Ϯ 0.5 mg·min Ϫ1 ·kg Ϫ1 ; CON: 6.8 Ϯ 0.5 mg·min 
·kg
Ϫ1 in IUGR and CON (between groups: P Ͼ 0.05), respectively, as described previously (42) .
Subcutaneous adipose tissue lipolysis. The basal rate of SCAAT lipolysis was higher in IUGR compared with CON both before and after bed rest (difference before bed rest: 106 nmol·100 g
, 95%CI 13-199, P ϭ 0.03; difference after bed rest: 124 nmol·100 g Ϫ1 ·min
Ϫ1
, 95%CI 37-211, P ϭ 0.007) (Fig. 1) . Bed rest did not influence SCAAT lipolysis in any of the groups. Insulin inhibited SCAAT lipolysis in both IUGR (decrease before bed rest: 146 nmol·100 g Ϫ1 ·min Ϫ1 , 95%CI 82-211, P ϭ 0.0001; decrease after bed rest: 129 nmol·100 g Ϫ1 ·min
, 95%CI 60 -197, P ϭ 0.001) and CON (decrease before bed rest: 73 nmol·100 g Ϫ1 ·min Ϫ1 , 95%CI 23-123, P ϭ 0.007; decrease after bed rest: 69 nmol·100 g Ϫ1 ·min Ϫ1 , 95%CI 34 -104, P ϭ 0.0006) with no difference in the relative decrease upon insulin stimulation.
SCFAT lipolysis did not differ between groups before or after bed rest (Fig. 1) . Bed rest decreased basal SCFAT lipolysis in CON (53 nmol·100 g Ϫ1 ·min Ϫ1 , 95%CI 28 -133, P ϭ 0.02) while basal SCFAT lipolysis remained unchanged in IUGR. Insulin inhibited SCFAT lipolysis in both IUGR (decrease before bed rest: 182 nmol·100 g Ϫ1 ·min Ϫ1 , 95%CI 108 -256, P Ͻ 0.0001; decrease after bed rest: 173 nmol·100 g Ϫ1 ·min Ϫ1 , 95%CI 89 -258, P ϭ 0.0004) and CON (decrease before bed rest: 151 nmol·100 g Ϫ1 ·min Ϫ1 , 95%CI 89 -213, P Ͻ 0.0001; decrease after bed rest: 94 nmol·100 g Ϫ1 ·min Ϫ1 , 95%CI 15-173, P ϭ 0.02) with no difference in the relative decrease upon insulin stimulation.
Subcutaneous adipose tissue glucose uptake. Basal and insulin-stimulated SCAAT glucose uptake did not differ between IUGR and CON before or after bed rest (Fig. 2) . In CON, SCAAT basal and insulin-stimulated glucose uptake increased in response to bed rest (increase basal: 1.1 mol·100 g Ϫ1 ·min Ϫ1 , 95%CI 0.3-1.9, P ϭ 0.01; increase insulin stimulated: 0.7 mol·100 g Ϫ1 ·min Ϫ1 , 95%CI 0.1-1.4, P ϭ 0.02), while bed rest did not change basal or insulin-stimulated glucose uptake in IUGR. Insulin did not stimulate SCAAT glucose uptake in any of the groups.
Before bed rest, insulin-stimulated, but not basal, SCFAT glucose uptake was higher in IUGR compared with CON (difference insulin stimulated: 44%, 95%CI 3-69, P ϭ 0.05), but after bed rest glucose uptake did not differ between groups (Fig. 2) . Only in IUGR, basal and insulin-stimulated SCFAT glucose uptake decreased in response to bed rest (decrease basal: 45%, 95%CI 13-65, P ϭ 0.01; decrease insulin stimulated: 51%, 95%CI 13-73, P ϭ 0.02). Insulin did not stimulate SCFAT glucose uptake.
Subcutaneous adipose tissue lactate release. SCAAT as well as SCFAT lactate release did not differ significantly between the groups before or after bed rest and did not change significantly in response to bed rest or insulin stimulation (data not shown).
Subcutaneous adipose tissue blood flow.
Basal SCAAT and SCFAT blood flow were higher in IUGR compared with CON before bed rest (SCAAT: P ϭ 0.02; SCFAT: P ϭ 0.004) ( Table 2 ) but did not differ significantly between the groups after bed rest.
Arterial plasma glycerol, glucose, lactate, free fatty acids, triglyceride, and insulin levels. Plasma glycerol did not differ between IUGR and CON and did not change in response to bed rest but decreased upon insulin stimulation in both groups (P Ͻ 0.0001; Table 3 ). Plasma glucose also did not differ between IUGR and CON but decreased in response to bed rest in both groups (P Ͻ 0.0001). Plasma lactate did not differ between groups and in CON, plasma lactate during insulin stimulation decreased slightly (P ϭ 0.03) after bed rest. Plasma free fatty Fig. 1 . Subcutaneous abdominal and femoral adipose tissue lipolysis in the basal (no pattern) and the insulin-stimulated state (patterned) before (gray) and after (black) 10 days of bed rest (BR) in controls (CON) and intrauterine growth retardation (IUGR) subjects. Abdominal adipose tissue: *basal state before bed rest in CON vs. IUGR (P ϭ 0.03). **Basal state after bed rest in CON vs. IUGR (P ϭ 0.007). ***Basal vs. insulinstimulated state before bed rest in CON (P ϭ 0.007) and in IUGR (P ϭ 0.0001). ****Basal vs. insulin-stimulated state after bed rest in CON (P ϭ 0.0006) and in IUGR (P ϭ 0.001). Femoral adipose tissue: ϩbasal state before vs. after bed rest in CON (P ϭ 0.02). ϩϩBasal vs. insulin-stimulated state before bed rest in CON (P ϭ 0.0001) and in IUGR (P ϭ 0.0001). ϩϩϩBasal vs. insulin-stimulated state after bed rest in CON (P ϭ 0.02) and in IUGR (P ϭ 0.0004). Fig. 2 . Subcutaneous abdominal and femoral adipose tissue glucose uptake in the basal (no pattern) and the insulin-stimulated state (patterned) before (gray) and after (black) 10 days of BR in CON and IUGR subjects. Abdominal adipose tissue: *basal (P ϭ 0.01) and insulin-stimulated state (P ϭ 0.02) before vs. after bed rest in CON. Femoral adipose tissue: ϩinsulin-stimulated state before bed rest in CON vs. IUGR (P ϭ 0.05). ϩϩBasal (P ϭ 0.01) and insulin-stimulated state (P ϭ 0.02) before vs. after bed rest in IUGR.
acids and triglyceride did not differ between IUGR and CON and did not change in response to bed rest. Insulin decreased plasma free fatty acids (P Ͻ 0.0001) and triglyceride (P Ͻ 0.001) levels in both groups before and after bed rest. Plasma insulin did not differ between IUGR and CON before bed rest, but after bed rest basal plasma insulin levels were higher in IUGR (P Ͻ 0.05) compared with CON as plasma insulin increased in response to bed rest in IUGR (P Ͻ 0.05) but not in CON.
ATGL, HSL, LPL, and GLUT4 mRNA expression in subcutaneous abdominal adipose tissue. Basal ATGL expression was lower in IUGR compared with CON before and after bed rest (P ϭ 0.01; Fig. 3A) . Only in IUGR, insulin-stimulated ATGL expression (P ϭ 0.003) decreased in response to bed rest and increased upon insulin stimulation before but not after bed rest (P ϭ 0.0007). Basal HSL expression was also lower in IUGR compared with CON both before and after bed rest (P ϭ 0.01; Fig. 3B ) and did not change in response to bed rest in any of the groups. Only in IUGR, HSL expression increased during insulin stimulation before (P ϭ 0.0006) and after (P ϭ 0.0003) bed rest. Similar to ATGL and HSL expression, basal LPL expression was lower in IUGR compared with CON before and after bed rest (P ϭ 0.02; Fig. 3C ). In CON, basal LPL expression increased markedly in response to bed rest (P ϭ 0.02). In IUGR, LPL expression increased upon insulin stimulation before bed rest (P ϭ 0.005). Insulin-stimulated, but not basal GLUT4 expression, was higher in IUGR compared with CON before and after bed rest (P ϭ 0.003; Fig. 3D ). GLUT4 expression did not change in response to bed rest in IUGR or CON. Before bed rest, insulin did not influence GLUT4 expression, but after bed rest, insulin increased GLUT4 expression in both IUGR and CON (P ϭ 0.02).
DISCUSSION
The present study showed that a range of metabolic alterations in adipose tissue, including increased in vivo lipolysis and blood flow and decreased mRNA expression of lipases, precedes the development of overt whole body insulin resistance in young adults born with IUGR.
In a recent study (1), using the stable isotope tracer technique, we showed that IUGR subjects exhibit an increased rate of whole body lipolysis (rate of appearance of glycerol) compared with CON, and in the present study we expand this finding by nailing down the enhanced lipolytic activity to SCAAT, but not SCFAT, by use of the microdialysis technique. Also, in the present study IUGR had a higher proportion of adipose tissue localized to the trunk compared with CON, which, in combination with an enhanced SCAAT lipolysis (expressed per tissue weight), would contribute to the high whole body lipolysis in IUGR (1) .
Another novel finding of the present study is the increased adipose tissue blood flow in IUGR compared with CON. The finding of a high adipose tissue blood flow in IUGR is exciting as a high blood flow promotes free fatty acid mobilization from lipolytically active tissue (7), and thus not only adipose tissue lipolysis, but probably also free fatty acid release, was increased in IUGR compared with CON. As previously discussed (1), the unaltered plasma free fatty acid level in IUGR Data are presented as mean Ϯ SE in ml ⅐ 100 g Ϫ1 ⅐ min Ϫ1 . *Significant difference control vs. intrauterine growth retardation subjects before bed rest (P Ͻ 0.05). Data are presented as means Ϯ SE. *Significant difference control vs. intrauterine growth retardation subjects (P Ͻ 0.05). †Significant difference before vs. after bed rest within the group (P Ͻ 0.05). ‡Significant difference basal vs. insulin-stimulated state within the group on the specified day (P Ͻ 0.05).
a Data were log transformed before statistical test. compared with CON indicates that the removal rate of free fatty acids from plasma is most likely also increased in IUGR. Interleukin-6 infusion has been shown to increase adipose tissue blood flow (30), and we speculate that the increased adipose tissue blood flow in IUGR subjects is an early sign of dysregulation induced by low-grade inflammation. Systemic low-grade inflammation has been suggested as a cause of insulin resistance, but data on cytokine profile in IUGR subjects are scarce and contradictory (31) .
Despite increased SCAAT lipolysis in IUGR compared with CON subjects, we found that basal SCAAT mRNA expression of ATGL, HSL, and LPL is markedly decreased in IUGR compared with CON. We previously found a low SCAAT expression of lipases in first degree relatives of type 2 diabetics (16) despite similar in vivo lipolysis compared with CON, and a low adipose tissue lipase expression may thus be a general feature of prediabetic subjects. The coexistence of increased in vivo lipolysis with decreased mRNA expression of lipases in SCAAT of IUGR subjects remain an unexplained paradox. The phenomenon could be explained by posttranscriptional and -translational modifications and emphasizes the importance of measuring in vivo metabolism and perhaps protein levels that may not always be reflected by a cross-sectional mRNA expression. A low mRNA expression of HSL has been shown previously in subjects with insulin resistance (50), but we did not find a significant difference in insulin sensitivity between IUGR and CON either before or after bed rest. Another explanation for the lower mRNA expression of lipases in IUGR could be related to low-grade inflammation in adipose tissue as mRNA levels of lipases are affected by inflammatory substances. In a study by Doerller et al. (11) , incubation of isolated adipocytes with inflammatory cytokines revealed that cytokine-induced changes in lipase activity and mRNA expression were not parallel. Hence enzyme mRNA content is not necessarily directly reflected in enzyme function. The study also demonstrated that cytokines in general induce lipolysis, but that, for example, TNF-␣ induced a reduction in mRNA HSL content. Differences in inflammatory markers between IUGR and CON might thus contribute to explain the low mRNA expression of lipases despite the high in vivo lipolysis in IUGR subjects.
We found similar basal GLUT4 mRNA as well as glucose uptake in SCAAT of IUGR and CON subjects, but insulinstimulated SCAAT GLUT4 mRNA expression was higher in IUGR compared with CON. In contrast to us, Jaquet et al. (20) found insulin-stimulated SCAAT GLUT4 mRNA to be decreased in IUGR subjects. A difference between the two studies was that the IUGR subjects of the other study (20) were insulin resistant, whereas our IUGR subjects were not. We previously found GLUT4 protein to be decreased in muscle (34) and adipose tissue (33) obtained from young, healthy men with IUGR. Nevertheless, our finding of a disproportionately upregulation of the GLUT4 mRNA levels in adipose tissue during acute insulin infusion is consistent with our previous finding of a disproportionately upregulated GLUT4 protein level in skeletal muscle during an acute insulin infusion in IUGR subjects (21) . The explanation for such a paradoxical acute upregulation of GLUT4 in both muscle and adipose tissue by insulin in IUGR subjects remains elusive, but could to some extent reflect the increased local tissue blood flow and thus increased delivery of insulin and glucose to the tissues.
A physiological concentration of insulin did not stimulate in vivo adipose tissue glucose uptake in the present or in our recent study (10) . In contrast, in vivo adipose tissue lipolysis was very sensitive to insulin and was suppressed at a physiological insulin concentration to the same extent in IUGR and CON. The relatively limited ability of insulin to stimulate glucose uptake in human adipose tissue has also been found in previous studies using microdialysis (12) as well as arteriovenous flux (8) techniques. In our recent study (10) , adipose tissue glucose uptake was increased significantly only at a supraphysiological insulin concentration (13.000 pmol/l), while increasing doses of insulin stimulated in vivo glucose uptake in skeletal muscle in a stepwise fashion. Fig. 3 . Subcutaneous abdominal adipose tissue triglyceride lipase (ATGL), hormone-sensitive lipase (HSL) and lipoprotein lipase (LPL) mRNA expression relative to GAPDH and GLUT4 mRNA expression relative to ␤-actin in the basal state (no pattern) and the insulin-stimulated state (patterned) before (gray) and after (black) 9 days of BR in CON and IUGR subjects. A: ATGL: *basal state before bed rest in CON vs. IUGR (P ϭ 0.01). **Basal state before vs. after bed rest in CON vs. IUGR (P ϭ 0.01). ***Insulin-stimulated state before vs. after bed rest in IUGR (P ϭ 0.003). ****Basal vs. insulinstimulated state before bed rest in IUGR (P ϭ 0.0007). B: HSL: *basal state before bed rest in CON vs. IUGR (P ϭ 0.01). **Basal state after bed rest in CON vs. IUGR (P ϭ 0.01). ***Basal vs. insulin-stimulated state before bed rest in IUGR (P ϭ 0.0006). ****Basal vs. insulinstimulated state after bed rest in IUGR (P ϭ 0.0003). C: LPL: *basal state before bed rest in CON vs. IUGR (P ϭ 0.02). **Basal state after bed rest in CON vs. IUGR (P ϭ 0.02). ***Basal state before vs. after bed rest in CON (P ϭ 0.02). ****Basal vs. insulin-stimulated state before bed rest in IUGR (P ϭ 0.005). D: GLUT4: *insulin-stimulated state before bed rest in CON vs. IUGR (P ϭ 0.003). **Insulin-stimulated state after bed rest in CON vs. IUGR (P ϭ 0.003). ***Basal vs. insulin-stimulated state after bed rest in CON (P ϭ 0.02). ****Basal vs. insulin-stimulated state after bed rest in IUGR (P ϭ 0.02).
Ten days of bed rest clearly induced whole body insulin resistance in both IUGR and CON subjects as evidenced by a decrease in M-value and an increase in fasting plasma insulin in IUGR subjects. The M-value primarily represents insulinstimulated glucose uptake in skeletal muscle, and we also previously found a bed rest-induced decrease in forearm insulin-stimulated glucose clearance in both IUGR and CON subjects (44) . Conversely, in the present study, SCAAT glucose uptake was increased after bed rest in CON subjects, as also discussed in a previous publication (16) , and SCAAT GLUT4 expression was stimulated by insulin after but not before bed rest in both IUGR and CON subjects. This may suggest a differential phenotype in skeletal muscle and adipose tissue of CON subjects during development of insulin resistance as also proposed by others previously (9) . However, in IUGR subjects bed rest did not increase in vivo adipose tissue glucose uptake in SCAAT, and glucose uptake even decreased after bed rest in SCFAT. The inability of subcutaneous adipose tissue and skeletal muscle to adequately redirect increased plasma glucose imposed by decreased insulin sensitivity in response to bed rest in the IUGR subjects would channel glucose toward other tissues, such as liver and visceral adipose tissue, where it can be stored as glycogen or triacylglycerol, and in fact a high visceral adipose tissue mass has been found in IUGR subjects in both cross-sectional studies of adults (40) and longitudinal studies of children (18) .
The relatively high lipolytic activity of SCAAT in IUGR compared with CON subjects persisted after bed rest. Furthermore, basal SCFAT lipolysis did not decrease in response to physical inactivity in IUGR as in CON, which would be expected as a normal physiological adaptation to a decreased energy turnover. We previously found by use of stable isotope tracer technique that bed rest induced a decrease in whole body lipolysis in IUGR as well as in CON subjects (1) . Stable isotope tracer technique does not allow a distinction between adipose tissue and skeletal muscle lipolysis, and the bed rest-induced decrease in whole body lipolysis occurred simultaneous to a decreased activation of HSL in skeletal muscle (1) . In comparison, we found no change in HSL expression in SCAAT after bed rest. We thus suggest that physical inactivity primarily decreases lipolysis in skeletal muscle, but that adipose tissue lipolysis under some circumstances also might be affected.
In conclusion, prior to the development of whole body insulin resistance, healthy young men with IUGR display an abnormal metabolic phenotype with central fat deposition and increased in vivo adipose tissue lipolysis and blood flow, as well as a paradoxically decreased expression of lipases in SCAAT, and IUGR subjects thus exhibited primary defects in subcutaneous adipose tissue metabolism compared with CON subjects. Trying to unmask further metabolic disturbances in IUGR subjects by 10 days of physical inactivity underlined the initial findings and revealed that excess amounts of glucose during development of insulin resistance is not taken up in SCAAT in IUGR as in CON, which could represent one of the first signs of an adverse metabolic condition.
